Systems and methods for ex vivo lung care

• US 9,516,875 B2
• Filed: 02/12/2013
• Issued: 12/13/2016
• Est. Priority Date: 01/31/2008
• Status: Active Grant

• Current Assignee: TransMedics, Inc. (TransMedics Group, Inc.)
• Original Assignee: TransMedics, Inc. (TransMedics Group, Inc.)
• Inventors: Fattah, Ihab A., Bishop, Thomas H., Khayal, Tamer I., Taylor, Ron Jr., Fishman, Robert, Havener, Robert, Abdelazim, Anas, Newell, Scott, Kyi, Stanley, Harriott, Doug, De Remer, Matthew, Murray, Paul, Sullivan, John, Anderson, Mark, Bringham, Richard, Van Driel, Michael, Hassanein, Waleed H.
• Primary Examiner(s): Gitomer, Ralph
• Assistant Examiner(s): CLARKE, TRENT R
• Application Number:
  US13/765,009
• Publication Number:
  US 20130157248A1
• Time in Patent Office: 1,400 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A01N 1/02 Preservation of living parts
• CPC Class Codes: A01N 1/021 Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
• CPC Class Codes: A01N 1/0247 for perfusion, i.e. for circulating fluid through organs, blood vessels or other living parts

Abstract

Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.

Claims

1. A method of preserving a lung ex vivo comprising:

circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface;

ventilating the lung through a tracheal interface by flowing a captive volume of a ventilation gas back and forth between the lung and a variable volume chamber; and

introducing into the captive volume an additional flow of the ventilation gas wherein the additional flow is about 10% of a tidal volume and venting excess ventilation gas from the captive volume using a pneumatic control system that controls at least a valve to maintain a predetermined composition of the ventilation gas and to maintain a minimum gas pressure of the captive volume.

2. The method of claim 1, wherein the ventilation gas includes a composition of oxygen, carbon dioxide and an inert gas.

3. The method of claim 2, wherein the inert gas is nitrogen.

4. The method of claim 1, wherein a gas content of the perfusion fluid reaches an equilibrium level corresponding to the predetermined composition of the ventilation gas.

5. The method of claim 1, wherein the predetermined composition of the ventilation gas includes about 5-20% oxygen and about 2-10% carbon dioxide.

6. The method of claim 5, wherein a gas content of the perfusion fluid reaches an equilibrium level, the equilibrium level having a hemoglobin saturation level of about 88%-98%.

7. The method of claim 1, wherein the predetermined composition of the ventilation gas includes about 12% oxygen and about 5.5% carbon dioxide.

8. The method of claim 7, wherein a hemoglobin saturation level of the perfusion fluid entering the lung reaches an equilibrium level of about 90-95% and a hemoglobin saturation level of the perfusion fluid leaving the lung reaches an equilibrium level of about 90-95%.

9. The method of claim 1, wherein an oxygen content of the perfusion fluid entering the lung is lower than physiologic levels, and an oxygen content of perfusion fluid leaving the lung is higher than physiologic levels.

10. The method of claim 1, wherein the additional flow of ventilation gas is about 400-600 mL per minute.

11. The method of claim 1, wherein the captive volume is about 400-1200 mL.

12. The method of claim 1, wherein the minimum gas pressure of the captive volume is about 4-8 cm of H₂O.

13. The method of claim 1, wherein a maximum pressure of the ventilation gas is about 12-22 cm of H₂O.

14. The method of claim 1, wherein the excess ventilation gas is vented through a relief valve in communication with the captive volume.

15. The method of claim 1, wherein the variable volume chamber comprises a bellows.

16. The method of claim 15, further comprising compressing the bellows to cause the flow of ventilation gas into the lung.

17. The method of claim 16, wherein a volume of ventilation gas that is flowed between the bellows and the lung is determined by a magnitude of a compression stroke of the bellows.

18. The method of claim 1, wherein the flow of ventilation gas out of the lung is caused by contraction of the lung.

19. The method of claim 1, wherein the pulmonary artery interface includes a pulmonary artery cannula, a portion of the pulmonary artery cannula being inserted into a pulmonary artery of the lung.

20. The method of claim 1, wherein the perfusion fluid flows away from the lung through an exposed left atrial cuff.

21. The method of claim 1, wherein the left atrial interface includes a sealed connection between a left atrium of the lung and a left atrial cannula.

22. The method of claim 1, wherein the tracheal interface includes a tracheal cannula, a portion of the tracheal cannula being inserted into a trachea of the lung.

23. The method of claim 1, wherein the perfusion fluid is maintained at a near physiologic temperature.

24. The method of claim 1 further comprising measuring a first level of oxygen content in the perfusion fluid flowing into the lung and a second level of oxygen content in the perfusion fluid flowing out of the lung.

25. The method of claim 1 further comprising measuring at least one of a level of oxygen saturation of hemoglobin in the perfusion fluid and a partial pressure of oxygen in the perfusion fluid flowing into the lung.

26. The method of claim 1 further comprising measuring at least one of a level of oxygen saturation of hemoglobin in the perfusion fluid and a partial pressure of oxygen in the perfusion fluid flowing out of the lung.

27. The method of claim 1, wherein the perfusion fluid comprises a blood product.

28. The method of claim 27, wherein the perfusion fluid is at least partially depleted of leukocytes.

29. The method of claim 28, wherein the perfusion fluid is at least partially depleted of platelets.

30. The method of claim 1, wherein the perfusion fluid comprises whole blood.

31. The method of claim 1, further comprising delivering one or more therapeutics to the lung during perfusion.

32. The method of claim 31, wherein the one or more therapeutics are selected from antimicrobials, vasodilators, and anti-inflammatory drugs.

33. The method of claim 31, wherein the one or more therapeutics are selected from the group consisting of prostaglandins, prostacyline, dextran, isuprel, flolan, and nitric oxide donors.

34. The method of claim 31, wherein the one or more therapeutics are delivered through the tracheal interface through one of a nebulizer and a bronchoscope.

35. The method of claim 1, further comprising establishing a desired level of oxygen content in the perfusion fluid prior to initiating perfusion of the lung.

36. The method of claim 35, wherein the desired level of oxygen content in the perfusion fluid corresponds to a hemoglobin saturation level of about 88%-98%.

37. A method of preserving a lung ex vivo comprising:

circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface;

ventilating the lung through a tracheal interface by flowing a captive volume of a ventilation gas back and forth between the lung and a variable volume chamber;

introducing into the captive volume an additional volume of the ventilation gas wherein the additional volume of the ventilation gas is about 10% of a tidal volume and venting excess ventilation gas from the captive volume using a pneumatic control system that controls at least a valve to maintain a predetermined composition of the ventilation gas and to maintain a minimum gas pressure of the captive volume; and

wherein a gas exchange in the lung between a component of the ventilation gas and the perfusion fluid causes the corresponding gas component in the perfusion fluid to reach an equilibrium value.

38. The method of claim 37, wherein the component of the ventilation gas is at least one of oxygen and carbon dioxide.